With reference to the earlier announcement dated October 12, 2013 regarding Delisting Updates. Fresenius Kabi Oncology Ltd has now informed BSE that Securities and Exchange Board of India (SEBI), vide its letter dated October 14, 2013, has advised the Company to approach Securities Appellate Tribunal (SAT) for seeking any relief including extension of time.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
